BUB1B promotes cisplatin resistance in gastric cancer via Rad51-mediated DNA damage repair
BUB1B enhances cisplatin resistance in gastric cancer by regulating DNA repair and cell cycle progression, suggesting that targeting BUB1B may be a feasible therapeutic strategy.
Authors
- Fangzhou Ye
- Huanqing Li (ORCID: https://orcid.org/0000-0002-1933-2211)
- Xiaohong Zhang (ORCID: https://orcid.org/0000-0002-2404-517X)
- Feng Li (ORCID: https://orcid.org/0000-0002-0045-1501)
- Jiayi Wang (ORCID: https://orcid.org/0000-0003-1688-2864)
- Jun Jiang (ORCID: https://orcid.org/0000-0002-6116-5605)
- Zhe Qin
Institutions
- Fudan University (CN)
- Obstetrics and Gynecology Hospital of Fudan University (CN)
Publication Details
- Journal
- Translational Oncology
- Published
- 2025-03-07
- DOI
- https://doi.org/10.1016/j.tranon.2025.102334
- Citations
- 3
- Primary Topic
- DNA Repair Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 2.42